University of Minnesota. Driven to Discover.
Researchers are relieved to resume experiments, but some public health questions remain.
In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.
A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.
Recommendations focus on public-private R&D funding, incentives, and other steps.
The review didn't find any new evidence to drive policy changes, but said more research and new antivirals are needed.
The study says the funding has spurred growth of US jobs while bringing lifesaving products to the world.
In other Zika developments, a human rights group raised concerns about water, sanitation, and other public health concerns in Brazil, and India announced microcephaly screening for newborns.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.